Celgene is a biopharmaceutical company that discovers, develops and commercialises innovative therapies for the treatment of cancer and other serious inflammatory diseases. Celgene is a medium-sized company which invests double the pharmaceutical industry average into scientific research, driving clinical advances in fatal and rare diseases, and diseases with the biggest unmet medical need, to develop medicines that bring value to healthcare systems.
Celgene has been operating in Portugal since 2007, currently, employing 17 people dedicated to marketing and sales operations, and medical education. One third of employees focus exclusively on medical and clinical research, covering five main areas of activity: regulatory and safety, market access, clinical research, external and public relations, and medical education.
Social responsibility:
Celgene Portugal collaborates with most of existing hematologic and oncologic associations in Portugal contributing to their initiatives to support the patients and careers; namely, fund-raising, educational sessions about the disease, and the rights of the patients.
Celgene Portugal is committed not only to provide up-to-date information on the management of the diseases, but essentially to support a local platform for the existing three hematologic associations in Portugal and facilitating networking with the European counterparts as well. This will allow patient groups to share best practice in patient advocacy and become better equipped to support the patients and careers who use their services, optimizing resources and broad coverage of supporting patients in Portugal independent of their local of living.
Fermin Rivas Lopez, Country Manager of Celgene Portugal, gives his insight on Portugal’s recent economic problems, the challenges Celgene Portugal faces due to the economic state of the country, and…
From software development to sales and consultancy, Alexandre Leiria today heads up the Life Sciences, Healthcare, and Manufacturing arm of digital-focused consultancy Capgemini in Portugal. He discusses Capgemini’s role in…
Dr João Filipe Raposo outlines the importance of a collaborative, multidisciplinary approach to diabetes care management, an approach embodied by the APDP – Diabetes Portugal. He also touches on the…
Nuno Sousa details the development of Portugal’s clinical research ecosystem, highlighting the creation of the Clinical Academic Center of Braga (2CA-Braga) and its evolution. He emphasises the necessity of building…
Joana Branco of Biocant Park, Portugal’s pioneering biotech hub, delves into its strategic development and international impact since 2005. Branco highlights Biocant’s role in advancing the Portuguese life sciences sector,…
APDP is the association for people living with diabetes in Portugal, and the oldest such institution in the world. Deputy Clinical Director Dr Carolina Neves emphasises the APDP’s patient-centred approach…
Marco Dietrich highlights some of the key challenges in Portugal’s healthcare system, Bayer Portugal’s continuing focus on introducing new products – particularly in diabetes, where Portugal has the highest prevalence…
A staunch advocate for diversity and inclusion, Helena Freitas today leads the Portuguese affiliate of Sanofi, consistently ranked among the leading pharmaceutical firms in the country. With a focus on…
Pfizer holds a prominent position in Portugal’s pharmaceutical landscape, especially in the hospital business and for COVID-19-related products, with the emphasis now on sustainable growth post-COVID. Paulo Teixeira, a 26-year…
Ana Fereira highlights how the twin factors of people and time have shaped her leadership approach, how she is navigating the challenging generic medicines landscape in Portugal, and why STADA…
Mario Martins lays out IQVIA Portugal’s holistic approach to the healthcare sector, covering clinical trials, therapeutic studies, and technology solutions such as compliance CRM and quality control for manufacturing plants.…
Health Cluster Portugal is currently spearheading a EUR 90 million EU post-COVID Recovery and Resilience Plan (RRP) project in Portugal focused on smart health, secondary use of data, and clinical…
Sérgio Alves describes the personal and professional factors that drove his return to Portugal, where he draws on enriching experiences gained from working in various European markets. He also discusses…
See our Cookie Privacy Policy Here
